Tokyo, Aug. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062466) titled 'Demonstration experiment on MCI and frailty countermeasures using ingredients from Kyushu' on Aug. 4.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - Saishunkan Pharmaceutical Co., Ltd.
Condition:
Condition - Healthy Adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To objectively evaluate changes in cognitive function scores, physical and daily function (frailty) scores, and blood protein profiles (proteomics analysis) before and...